Eniko Papp
About Eniko Papp
Eniko Papp is a Principle Scientist in Translational Research, Immuno-Oncology and Cell Therapy at Bristol Myers Squibb in Seattle, Washington. She has extensive experience in translational medicine, having held multiple leadership roles at various organizations, including AstraZeneca and Personal Genome Diagnostics.
Company
Eniko Papp is currently employed at Bristol Myers Squibb as a Principle Scientist in Translational Research, Immuno-Oncology, and Cell Therapy (IOCT) located in Seattle, Washington, United States.
Title
Eniko Papp holds the title of Principle Scientist, Translational Research, Immuno-Oncology, and Cell Therapy (IOCT).
Education and Expertise
Eniko Papp has a robust academic background, holding a Doctor of Philosophy (PhD) in Medical Biophysics from the University of Toronto. She earned a Master's degree in Pathology and Cell Biology from Université de Montréal and a Bachelor of Science (B.S.) in Microbiology and Immunology from McGill University. Her extensive education supports her expertise in translational medicine, immuno-oncology, and cell therapy.
Professional Background
Eniko Papp has accumulated significant experience in translational medicine through leadership roles at various organizations. She worked at AstraZeneca as a Translational Medicine Lead and at Personal Genome Diagnostics in several roles, including Lead Scientist, Translational Medicine, Development Lead, Manager II, Product Development, and Scientist Manager, Genome Sciences. She contributed to genome sciences and product development, influencing advancements in these fields.
Postdoctoral Fellowship at Johns Hopkins Hospital
Eniko Papp completed a postdoctoral fellowship at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, where she focused on cancer research for three years.